Although not a focus of this paper, ALK has been reported to be highly expressed in breast cancer [69], and ALK gene amplifications and activating mutations have been identified in familial and sporadic neuroblastoma [70–75] and thyroid cancer [76]. The gene discussed is ALK; the disease is thyroid gland carcinoma.